Day One Biopharmaceuticals Agrees To Servier Buyout For $2.5 Billion
Investor's Business Daily • • business
Key Points:
- Investor’s Business Daily provides information solely for informational and educational purposes and does not offer investment advice or recommendations.
- The data is sourced from reliable providers but is not guaranteed for accuracy, timeliness, or suitability, and past performance does not predict future results.
- Authors and presenters may hold positions in the stocks they discuss, and no warranties are made regarding the advisability of any investment strategies.
- Real-time prices are provided by Nasdaq Last Sale but may not cover all markets; ownership and estimate data come from LSEG and FactSet respectively.
- All trademarks mentioned are owned by Investor’s Business Daily, LLC, and the content is subject to change without notice.
